Developer docs
API playgroundTry for free, no card

Search company profiles

Collate

Full company profile

uuid0000f8t

Namestring
Collate
Legal namestring
Collate Software, Inc.
Websiteurl
collate.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Collate Software, Inc. is an AI-native enterprise platform that automates documentation and regulatory paperwork for life sciences organizations, including pharmaceutical, biotechnology, medical device, and diagnostic companies. The platform is purpose-built for GxP-regulated workflows and addresses the full product lifecycle — from R&D through preclinical and clinical trials, quality management, regulatory submissions, and market delivery — using generative and agentic AI to process documents up to 10,000 pages with claimed time savings of 50–90% and over 90% accuracy. Core capabilities include GxP-compliant document automation and multi-jurisdictional compliance tools that manage regulatory requirements across geographies.

The company operates a direct enterprise field sales model targeting pharmaceutical, biotechnology, and medical device manufacturers, with contracts structured as Master Services Agreements with custom Order Forms and annual billing. Approximately 50 enterprise customers were onboarded between the first signed deal in May 2025 and early 2026, served through demo-driven consultative sales. The technical stack is described as modern AI/ML with Python, Go, TypeScript, and React, supported by a founding team drawn from NVIDIA, Amazon AGI, Google, PicnicHealth, Hippocratic AI, Facebook, Apple, and TikTok.

Collate was founded in 2024 by Surbhi Sarna (former CEO and Founder of nVision Medical, acquired by Boston Scientific for $275M, and former YC General Partner), Nate Smith (former CEO/CTO/Founder of Lever, acquired by Employ for $517M), and Jigish Patel (former architect at Netflix, Airbnb, Symantec, and VeriSign). The company is headquartered in San Francisco, has raised $125M across a $30M seed (January 2025) and $95M Series A (June 2026, led by Redpoint Ventures with First Round Capital, CRV, Conviction, and Y Combinator), and reached a post-money valuation of approximately $995M. Forbes named it to its Next Billion-Dollar Startups 2025 list.

Short descriptiontext

Collate is an AI-native enterprise platform that automates GxP-compliant documentation and regulatory paperwork for pharmaceutical, biotechnology, and medical device companies. The platform serves approximately 50 life sciences customers across the full product lifecycle from R&D through market delivery.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory documentation software, life sciences AI platform, GxP compliance automation, clinical trial documentation, pharmaceutical paperwork automation
Industry1 code
PRIMARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code2 codes
  • Software Publishers513210
  • Software Publishers51321
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Life Sciences Regulatory Documentation Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise SaaS Subscription
TypeSubscription Recurring
Description

Subscription-based SaaS model with annual invoicing (30-day payment terms). Enterprise agreements structured through Master Services Agreement and Order Forms with defined initial terms and automatic renewal provisions.

collate.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise custom pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Annual billing with 30-day payment terms.

collate.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Collate provides an AI-native, GxP-compliant enterprise software platform that automates and streamlines regulatory, clinical trial, quality management, and product development documentation for pharmaceutical, biotechnology, medical device, and diagnostic companies. The platform ingests and generates documents up to 10,000 pages, with claimed 50-90% time savings and over 90% accuracy, spanning the full product lifecycle from concept to market.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 50-90% reduction in document processing time
+2 more records
Product overview1 text field

Collate is an AI-native enterprise platform designed for the life sciences industry. The platform consists of GxP-compliant AI software that automates documentation and regulatory paperwork throughout the entire product lifecycle—from concept to market. The platform enables pharmaceutical companies, medical device manufacturers, and biotech firms to streamline regulatory filings, clinical trial documentation, quality management, and compliance processes. Capabilities span accelerate research and development, optimize preclinical and clinical trials, enhance quality management, and deliver products to market.

Product and service2 records
1Collate AI Platform for Life Sciences
CategoryLife Sciences Regulatory Documentation Software
Description

AI-native enterprise platform that automates regulatory filings, clinical trial documentation, quality management documents, and product development paperwork for pharmaceutical, biotechnology, medical device, and diagnostic companies across the full product lifecycle (R&D through commercialization).

2GxP-Compliant Software
CategoryRegulatory Compliance Software
Description

GxP-compliant AI software designed to automate and streamline highly regulated documentation and process workflows for pharmaceutical and life sciences organizations.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Yseop builds AI copilots specifically for life sciences regulatory and medical writing workflows, including automated CSR and submission document generation. It is the closest direct competitor to Collate, targeting the same pharma/biotech documentation automation use case with generative AI.

TypeDirect peer
Description

Arria provides natural language generation software purpose-built for regulated industries (life sciences, finance, energy) to automate report and compliance documentation. Like Collate, Arria sells NLG-as-software into enterprise compliance teams rather than as a custom service.

TypeBroad incumbent
Description

Veeva is the dominant SaaS platform for life sciences, spanning CRM, regulatory, quality, and clinical operations across nearly every major pharma. It is the incumbent Collate most directly competes against for enterprise regulatory and quality management budgets and has begun adding AI features to its suite.

TypeBroad incumbent
Description

IQVIA is the largest life sciences services and technology provider, combining CRO services with technology platforms for clinical, regulatory, and real-world evidence workflows. It serves the same pharma/biotech/medical device buyer as Collate with a much broader portfolio of offerings.

TypeBroad incumbent
Description

Medidata provides the leading clinical trial technology platform (Rave EDC, eCOA, RTSM) used by most large pharma sponsors. It overlaps with Collate on the clinical trial documentation and data management portion of the regulated life sciences workflow.

TypeBroad incumbent
Description

Benchling is a cloud R&D platform for biotech that centralizes molecular biology, process development, and lab workflows. It serves many of the same biotech customers as Collate and competes for adjacent portions of life sciences R&D software budgets.

7Oracle Health (Clinical One)
TypeBroad incumbent
Description

Oracle Health's Clinical One platform provides EDC, RTSM, and trial management for pharma sponsors, while its broader health portfolio touches EHR and regulatory data. It competes with Collate across clinical trial technology and adjacent regulated documentation.

TypeEmerging player
Description

Hippocratic AI builds LLM-powered agents for healthcare, with overlapping team pedigree (former Head of Engineering Sanchay Harneja led LLM healthcare agents there). Different end users (clinicians/patients vs. life sciences documentation teams) but very similar AI-for-regulated-healthcraft positioning.

TypeEmerging player
Description

PicnicHealth uses ML to structure medical records and clinical documents at scale across 100M+ pages. Founding engineer Benjamin Pastel previously built segmentation transformers and OCR at PicnicHealth, and the company tackles adjacent medical document intelligence.

TypeEmerging player
Description

Owkin applies AI to biopharma clinical research and drug development, including trial optimization and biomarker discovery with pharma partners. It targets the same pharma/biotech R&D buyer as Collate with AI tooling that complements rather than directly competes on documentation.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Collate

Life Sciences Regulatory Documentation Softwarecollate.com

Collate is an AI-native enterprise platform that automates GxP-compliant documentation and regulatory paperwork for pharmaceutical, biotechnology, and medical device companies. The platform serves approximately 50 life sciences customers across the full product lifecycle from R&D through market delivery.

What Collate does

Collate Software, Inc. is an AI-native enterprise platform that automates documentation and regulatory paperwork for life sciences organizations, including pharmaceutical, biotechnology, medical device, and diagnostic companies. The platform is purpose-built for GxP-regulated workflows and addresses the full product lifecycle — from R&D through preclinical and clinical trials, quality management, regulatory submissions, and market delivery — using generative and agentic AI to process documents up to 10,000 pages with claimed time savings of 50–90% and over 90% accuracy. Core capabilities include GxP-compliant document automation and multi-jurisdictional compliance tools that manage regulatory requirements across geographies.

The company operates a direct enterprise field sales model targeting pharmaceutical, biotechnology, and medical device manufacturers, with contracts structured as Master Services Agreements with custom Order Forms and annual billing. Approximately 50 enterprise customers were onboarded between the first signed deal in May 2025 and early 2026, served through demo-driven consultative sales. The technical stack is described as modern AI/ML with Python, Go, TypeScript, and React, supported by a founding team drawn from NVIDIA, Amazon AGI, Google, PicnicHealth, Hippocratic AI, Facebook, Apple, and TikTok.

Collate was founded in 2024 by Surbhi Sarna (former CEO and Founder of nVision Medical, acquired by Boston Scientific for $275M, and former YC General Partner), Nate Smith (former CEO/CTO/Founder of Lever, acquired by Employ for $517M), and Jigish Patel (former architect at Netflix, Airbnb, Symantec, and VeriSign). The company is headquartered in San Francisco, has raised $125M across a $30M seed (January 2025) and $95M Series A (June 2026, led by Redpoint Ventures with First Round Capital, CRV, Conviction, and Y Combinator), and reached a post-money valuation of approximately $995M. Forbes named it to its Next Billion-Dollar Startups 2025 list.

Collate firmographics

Firmographics
Name
Collate
Legal name
Collate Software, Inc.
Website
https://collate.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Collate is an AI-native enterprise platform that automates GxP-compliant documentation and regulatory paperwork for pharmaceutical, biotechnology, and medical device companies. The platform serves approximately 50 life sciences customers across the full product lifecycle from R&D through market delivery.
Ownership category
akta.pro rank

Collate industry classification

Industry
Product category
Life Sciences Regulatory Documentation Software
NAICS
Software Publishers (513210), Software Publishers (51321)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Regulatory documentation software
  • Life sciences AI platform
  • GxP compliance automation
  • Clinical trial documentation
  • Pharmaceutical paperwork automation

Where Collate is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Collate business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Enterprise SaaS Subscription: Subscription-based SaaS model with annual invoicing (30-day payment terms). Enterprise agreements structured through Master Services Agreement and Order Forms with defined initial terms and automatic renewal provisions.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise custom pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Collate product offering

Product offering

Core offering

Collate provides an AI-native, GxP-compliant enterprise software platform that automates and streamlines regulatory, clinical trial, quality management, and product development documentation for pharmaceutical, biotechnology, medical device, and diagnostic companies. The platform ingests and generates documents up to 10,000 pages, with claimed 50-90% time savings and over 90% accuracy, spanning the full product lifecycle from concept to market.

Product overview

Collate is an AI-native enterprise platform designed for the life sciences industry. The platform consists of GxP-compliant AI software that automates documentation and regulatory paperwork throughout the entire product lifecycle—from concept to market. The platform enables pharmaceutical companies, medical device manufacturers, and biotech firms to streamline regulatory filings, clinical trial documentation, quality management, and compliance processes. Capabilities span accelerate research and development, optimize preclinical and clinical trials, enhance quality management, and deliver products to market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Collate AI Platform for Life Sciences AI-native enterprise platform that automates regulatory filings, clinical trial documentation, quality management documents, and product development paperwork for pharmaceutical, biotechnology, medical device, and diagnostic companies across the full product lifecycle (R&D through commercialization).
  • GxP-Compliant Software GxP-compliant AI software designed to automate and streamline highly regulated documentation and process workflows for pharmaceutical and life sciences organizations.

Quantifiable outcome

  • 50-90% reduction in document processing time
  • +2 more outcomes

Companies that use Collate

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Collate technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature2 records

Collate partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Collate competitors and assessment

Company assessment

Direct peers

  • Yseop: Yseop builds AI copilots specifically for life sciences regulatory and medical writing workflows, including automated CSR and submission document generation. It is the closest direct competitor to Collate, targeting the same pharma/biotech documentation automation use case with generative AI.
  • Arria NLG: Arria provides natural language generation software purpose-built for regulated industries (life sciences, finance, energy) to automate report and compliance documentation. Like Collate, Arria sells NLG-as-software into enterprise compliance teams rather than as a custom service.

Broad incumbents

  • Veeva Systems: Veeva is the dominant SaaS platform for life sciences, spanning CRM, regulatory, quality, and clinical operations across nearly every major pharma. It is the incumbent Collate most directly competes against for enterprise regulatory and quality management budgets and has begun adding AI features to its suite.
  • IQVIA: IQVIA is the largest life sciences services and technology provider, combining CRO services with technology platforms for clinical, regulatory, and real-world evidence workflows. It serves the same pharma/biotech/medical device buyer as Collate with a much broader portfolio of offerings.
  • Medidata (Dassault Systèmes): Medidata provides the leading clinical trial technology platform (Rave EDC, eCOA, RTSM) used by most large pharma sponsors. It overlaps with Collate on the clinical trial documentation and data management portion of the regulated life sciences workflow.
  • Benchling: Benchling is a cloud R&D platform for biotech that centralizes molecular biology, process development, and lab workflows. It serves many of the same biotech customers as Collate and competes for adjacent portions of life sciences R&D software budgets.
  • Oracle Health (Clinical One): Oracle Health's Clinical One platform provides EDC, RTSM, and trial management for pharma sponsors, while its broader health portfolio touches EHR and regulatory data. It competes with Collate across clinical trial technology and adjacent regulated documentation.

Emerging players

  • Hippocratic AI: Hippocratic AI builds LLM-powered agents for healthcare, with overlapping team pedigree (former Head of Engineering Sanchay Harneja led LLM healthcare agents there). Different end users (clinicians/patients vs. life sciences documentation teams) but very similar AI-for-regulated-healthcraft positioning.
  • PicnicHealth: PicnicHealth uses ML to structure medical records and clinical documents at scale across 100M+ pages. Founding engineer Benjamin Pastel previously built segmentation transformers and OCR at PicnicHealth, and the company tackles adjacent medical document intelligence.
  • Owkin: Owkin applies AI to biopharma clinical research and drug development, including trial optimization and biomarker discovery with pharma partners. It targets the same pharma/biotech R&D buyer as Collate with AI tooling that complements rather than directly competes on documentation.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Collate social profiles

Digital presence

Collate financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Collate leadership team

Management profile

Number of profiles

Profiles9 records

Collate funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Collate M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Collate

What does Collate do?

Collate provides an AI-native, GxP-compliant enterprise software platform that automates and streamlines regulatory, clinical trial, quality management, and product development documentation for pharmaceutical, biotechnology, medical device, and diagnostic companies. The platform ingests and generates documents up to 10,000 pages, with claimed 50-90% time savings and over 90% accuracy, spanning the full product lifecycle from concept to market.

Is Collate a public or private company?

Collate is a private company. It is classified as venture growth investor backed and is currently operating.

When was Collate founded?

Collate was founded in 2024. It employs 11 to 50 people.

Where is Collate based?

Collate is headquartered in San Francisco, United States, in the North America region.

How does Collate make money?

One revenue line is on record: enterprise SaaS Subscription.

Who are Collate's main competitors?

Direct peers on record are Yseop and Arria NLG. Broad incumbents are Veeva Systems, IQVIA, Medidata (Dassault Systèmes), Benchling and Oracle Health (Clinical One). Emerging players are Hippocratic AI, PicnicHealth and Owkin.

Does Collate have an API?

No public API is recorded for Collate.

What industry is Collate in?

Collate's product category is Life Sciences Regulatory Documentation Software. Its primary akta.pro industry code is HLAGAOAC, Medical Writing & Clinical Documentation FSP. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CNBCSurbhi Sarna, Collate CEO: A Fortt Knox ConversationSurbhi Sarna, CEO and founder of Collate, appeared in a video interview to discuss her company's AI-native, GxP-compliant software that automates documentation processes for life-sciences companies bringing drugs and devices to market. The interview also covered her personal background, including how her hospitalization from ovarian cysts as a teenager led her to found nVision Medical, which was later acquired by Boston Scientific. The interview represents a company profile rather than a news announcement with specific financial metrics or strategic developments.Pulse 2.0Collate Raises $95 Million Series A To Expand AI Platform For Regulated Life Sciences WorkflowsCollate announced a $95 million Series A funding round led by Redpoint Ventures, First Round Capital, CRV, Conviction, and Y Combinator to expand its AI-native platform for regulated life sciences workflows. The company provides GxP-compliant software designed to automate and streamline highly regulated processes for pharmaceutical and life sciences organizations. Collate plans to continue expanding its platform as demand grows for AI tools capable of operating within complex regulatory frameworks.Pulse 2.0Collate Raises $95 Million Series A To Expand AI Platform For Regulated Life Sciences WorkflowsCollate raised $95 million in a Series A round led by Redpoint Ventures, First Round Capital, CRV, Conviction, and Y Combinator. The funding will support its AI-native, GxP-compliant platform for regulated life sciences workflows. The company plans to expand its platform as demand for AI tools in regulated environments grows.DiyatvusaCollate nears a $1 billion valuation and Harrison.ai growsHealthcare AI startup Collate has raised $95 million in new funding, valuing the San Francisco-based company at nearly $1 billion, less than two years after emerging from stealth mode with AI tools that help life sciences companies manage regulatory, clinical trial, and product development documents. The article also covers biometric identity verification company Clear's expansion into healthcare with a $6 million Medicare contract for patient identity verification, and Australian clinical AI provider Harrison.ai's growth to over 3,400 clinicians across 1,000 hospitals in 40 countries as it prepares for US market entry. These developments illustrate the broader trend of AI adoption in healthcare, ranging from reducing documentation workloads and streamlining regulatory processes to improving patient identity verification and accelerating medical imaging analysis.VentureburnCollate Raises $95M to Transform Life Sciences AICollate raised $95 million in a funding round led by Redpoint Ventures, pushing its valuation to nearly $1 billion and marking one of the fastest growth trajectories in the regulated SaaS space, having raised $125 million in under a year and a half. The San Francisco-based startup develops AI tools that automate life sciences documentation and regulatory paperwork, enabling pharmaceutical companies and medical device manufacturers to cut document processing time by 50 to 90 percent. The capital will be used to scale operations and expand into end-to-end clinical trial data management, automated quality systems, and multi-jurisdictional compliance tools.LinkedInJigish Patel - CollateJigish Patel announced Collate, a company applying AI to life science documentation, and raised a $30M seed round. The round was led by Redpoint, First Round, Conviction, and YC. Patel will return to founding after fifteen years.ForbesAI Startup Collate Raises $95 Million To Automate Life Sciences PaperworkTwo-time entrepreneur Surbhi Sarna has raised $95 million for Collate, a San Francisco-based AI startup that automates life sciences paperwork including regulatory filings and clinical trial documentation, at a valuation approaching $1 billion. Redpoint Ventures led the round, bringing Collate's total funding to $125 million since emerging from stealth 17 months ago, with the company claiming 50-90% time savings and over 90% accuracy on documents that can run up to 10,000 pages. Collate has signed approximately 50 customers including major pharmaceutical companies, medical device manufacturers, and biotech firms since its first customer in May 2025.The American Bazaar -Biotech startup Collate secures $30 million seed fund to automate paperworkCollate, founded by Surbhi Sarna, raised $30 million in seed funding led by Redpoint. The AI platform automates documentation for life sciences companies, valuing the company at over $100 million. Sarna aims to accelerate R&D and reduce time to market for new drugs and devices.ForbesThis YC Partner Just Raised $30 Million For An AI Startup Automating Paperwork For BiotechSurbhi Sarna, a Y Combinator partner, is leaving to launch Collate, an AI startup automating paperwork for life sciences companies. The company raised $30 million in seed funding led by Redpoint, valuing it at over $100 million. Sarna plans to hire quickly and target two or three large customers in the next few months.